94 related articles for article (PubMed ID: 20684209)
1. [The role of positron emission tomography in the detection of incidental gastrointestinal tract lesions in patients examined for lung cancer].
Isobe K; Hata Y; Sakaguchi S; Takai Y; Shibuya K; Takagi K; Homma S
Nihon Kokyuki Gakkai Zasshi; 2010 Jul; 48(7):482-7. PubMed ID: 20684209
[TBL] [Abstract][Full Text] [Related]
2. Role of fluoro-2-deoxyglucose positron emission tomography for the detection of gastrointestinal tract lesions in patients with lung cancer.
Isobe K; Hata Y; Sakaguchi S; Sato K; Sano G; Sugino K; Sakamoto S; Takai Y; Shibuya K; Takagi K; Homma S
Thorac Cancer; 2011 Nov; 2(4):190-195. PubMed ID: 27755851
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of FDG-PET imaging for the detection of gastrointestinal tract cancer in patients with suspected lung cancer].
Uesaka D; Demura Y; Umeda Y; Morikawa M; Nakanishi M; Kadowaki M; Mizuno S; Ameshima S; Miyamori I; Sasaki M; Ishizaki T
Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):899-905. PubMed ID: 17233385
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
5. Metastasis of the gastrointestinal tract: FDG-PET imaging.
Hayasaka K; Nihashi T; Matsuura T; Yagi T; Nakashima K; Kawabata Y; Ito K; Katoh T; Sakata K; Harada A
Ann Nucl Med; 2007 Aug; 21(6):361-5. PubMed ID: 17705017
[TBL] [Abstract][Full Text] [Related]
6. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.
Kamel EM; Thumshirn M; Truninger K; Schiesser M; Fried M; Padberg B; Schneiter D; Stoeckli SJ; von Schulthess GK; Stumpe KD
J Nucl Med; 2004 Nov; 45(11):1804-10. PubMed ID: 15534047
[TBL] [Abstract][Full Text] [Related]
7. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
8. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.
Israel O; Yefremov N; Bar-Shalom R; Kagana O; Frenkel A; Keidar Z; Fischer D
J Nucl Med; 2005 May; 46(5):758-62. PubMed ID: 15872347
[TBL] [Abstract][Full Text] [Related]
9. Incidental head and neck findings on 18F-fluoro-deoxy-glucose positron emission tomography computed tomography.
Williams SP; Kinshuck AJ; Williams C; Dwivedi R; Wieshmann H; Jones TM
J Laryngol Otol; 2015 Sep; 129(9):898-902. PubMed ID: 26206309
[TBL] [Abstract][Full Text] [Related]
10. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
11. Incidental colonic focal lesions detected by FDG PET/CT.
Gutman F; Alberini JL; Wartski M; Vilain D; Le Stanc E; Sarandi F; Corone C; Tainturier C; Pecking AP
AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527
[TBL] [Abstract][Full Text] [Related]
12. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
13. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
Brady MJ; Thomas J; Wong TZ; Franklin KM; Ho LM; Paulson EK
Radiology; 2009 Feb; 250(2):523-30. PubMed ID: 19188319
[TBL] [Abstract][Full Text] [Related]
14. Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer.
Chopra A; Ford A; De Noronha R; Matthews S
Br J Radiol; 2012 Jul; 85(1015):e229-37. PubMed ID: 22745208
[TBL] [Abstract][Full Text] [Related]
15. [18F-FDG PET/CT in response evaluation of gastrointestinal stromal tumours treated with imatinib].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla JF; Sainz-Esteban A; Barragán J; Portilla-Quattrociocchi H; Carril JM
Rev Esp Med Nucl; 2008; 27(3):168-75. PubMed ID: 18570858
[TBL] [Abstract][Full Text] [Related]
16. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
17. The clinical value of incidental 18F-fluorodeoxyglucose-avid foci detected on positron emission tomography/computed tomography.
Ozkol V; Alper E; Aydin N; Ozkol HF; Topal NB; Akpinar AT
Nucl Med Commun; 2010 Feb; 31(2):128-36. PubMed ID: 19858768
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R
Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838
[TBL] [Abstract][Full Text] [Related]
19. [Application of positron emission tomography in diagnosis and staging for lung cancer].
Wang MZ; Li LY; Zhu ZH; Song ZF
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):221-4. PubMed ID: 15854428
[TBL] [Abstract][Full Text] [Related]
20. Differentiating benign and malignant pulmonary lesions with FDG-PET.
Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY
Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
